newsfilter
← Latest News
Business Wire·

Magenta Therapeutics to Participate in Goldman Sachs 42nd Annual Global Healthcare Conference

Magenta Therapeutics (NASDAQ:MGTA), a clinical-stage biotechnology company developing novel medicines to bring the curative power of stem cell transplants to more patients, today announced that the company is scheduled to participate in a fireside chat